CP and bacterial infectious disease: In contrast, diabetic patients with bacterial infections showed different patterns: 42% fell into subgroups without any consumption for CP and AP and 59% for F3-LP and AP; while only 28% had a consumption of both pathways for CP and AP and 21% for F3-LP and AP.